Loading... Please wait...


02/01/2018 Librede receives a Phase II SBIR grant to scale their fermentation based cannabinoid production platform 


07/12/2017 Librede's patent issued for the production of cannabinoids in microorganisms; Production of Cannabinoids in Yeast #9,822,384


11/07/2016 Librede Inc. featured on the cover of the San Diego Business Journal


10/04/2016 Librede Inc. awarded NIH funding to optimize cannabinoid production in yeast

Librede has received a Phase I Small Business Innovative Research (SBIR) Grant from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH), to improve Cannabidiol (CBD) production in genetically engineered yeast.


03/14/2016 Librede receives a Phase I SBIR grant to develop cannabinoid production technology

Librede has been awarded a Phase I SBIR grant from the National Center for Complementary & Integrative Health. The project, Expression of Phytocannabinoids in Yeast: a High Yield Platform for Low Abundance Natural Products, will be lead by Dr. Farina, Chief Scientific Officer at Librede and co-inventor of Librede’s cannabinoid and drug discovery platform. 



Our Newsletter